CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
4.130
+0.220 (5.63%)
At close: Oct 14, 2026, 4:00 PM EDT
3.939
-0.191 (-4.63%)
After-hours: Oct 14, 2026, 7:56 PM EDT

CollPlant Biotechnologies Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.322.370.5210.960.315.64
Revenue Growth
-86.76%360.39%-95.30%3565.22%-98.09%154.86%
Gross Profit
-1.021.54-1.118.97-0.113.64
Operating Income
-12.41-11.48-17.25-7.51-17.10.07
Net Income
-12.51-11.49-16.61-7.02-16.930.24
Earnings Per Share
-9.32-9.41-14.50-6.16-15.340.20
EPS Growth
------

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States
0.032.180.4810.840.0214.95
Canada
0.150.1-0.090.160.06
Europe and Other
0.120.1-0.030.10.63
Israel
-00.030.010.02-
Total
0.322.370.5210.960.315.64

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2.565.5911.9126.6729.6543.3
Total Debt
2.662.853.083.162.913.61
Net Cash (Debt)
-0.12.758.8323.5226.7439.69
Net Cash Growth
--68.91%-62.46%-12.07%-32.63%-
Net Cash Per Share
-0.082.257.7120.6524.2433.17

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-11.19-9.42-14.09-2.76-13.72.5
Capital Expenditures
-0.09-0.03-0.48-0.95-1.27-1.43
Free Cash Flow
-11.29-9.45-14.58-3.72-14.971.07
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-64.78%-215.53%81.83%-33.78%87.18%
Operating Margin
-3900.94%-484.31%-3349.71%-68.55%-5718.06%0.42%
Pretax Margin
-3934.91%-484.56%-3225.05%-64.05%-5660.54%1.52%
Profit Margin
-3934.91%-484.56%-3225.05%-64.05%-5660.53%1.52%
FCF Margin
-3548.74%-398.44%-2830.29%-33.92%-5007.36%6.86%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----738.04
Forward PE
-11.4912.0212.0212.0217.40
P/FCF Ratio
-----163.01
PS Ratio
24.337.5480.076.68311.8911.18